siRNA, Anti-SLC16A10, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT66744WQ-2OMe)

The product SIRGT66744WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC16A10 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC16A10 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_018593.4
Alternative Names MCT10; PRO0813; TAT1
Related Diseases Allan-Herndon-Dudley Syndrome
Purification HPLC
Target Gene
Gene ID 117247
Uniprot ID Q8TF71
Sub Cat Target Species Modification Scale  
SIRGT67744WQ-2F SLC16A10 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT68744WQ-2MOE SLC16A10 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT69744WQ-LNA SLC16A10 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT66744WQ-RB SLC16A10 Human Ribo-modified Inquiry
SIRGT67744WQ-BB SLC16A10 Human Backbone-modified Inquiry

Related Products